Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 804 results for "Treatment For Multiple Sclerosis"

Multiple Sclerosis Therapeutics -Treatment Diversification, In...

The Report Multiple Sclerosis Therapeutics to 2019 - Treatment Diversification, Increasing Efficacy, and Pipeline Innovation Combine to Drive Growth provides information on pricing, market analysis, shares, forecast, and company profiles for key ... Digital Journal, 1 day ago

104 images for Treatment For Multiple Sclerosis

MedIndia, 1 month ago
HCPLive, 2 weeks ago
Manufacturing Chemist, 3 days ago, 1 month ago
ITechPost, 1 month ago
Washington University in St. Louis, 4 weeks ago
HCPLive, 1 month ago
PharmaVOICE, 2 months ago, 1 month ago
CBC, 1 month ago

Copaxone use during pregnancy by relapsing MS patients now possible in EU (08/12/16)

European users of Copaxone (glatiramer acetate injection, Teva Pharmaceutical ) to treat relapsing forms of multiple sclerosis will no longer see a warning that the drug should not be used during pregnancy. A report assessing this change in the ...
 MS-UK.org2 days ago Teva Copaxone EU Label to Omit Pregnancy Contraindication  Yahoo! Singapore2 days ago
International Business Times

Biohaven receives US FDA orphan drug status for BHV-0223 to treat amyotrophic lateral sclerosis

Biohaven Pharmaceutical Holding Company Ltd.,a privately-held biopharmaceutical company, announced that the US Food and Drug Administration (FDA) has granted the company's orphan drug designation request covering its drug candidate BHV-0223, an ...
 PharmaBiz1 day ago PORTAGE BIOTECH : Biohaven' BHV-0223 is Granted Orphan Drug Designation in the Treatment of Amyotrophic Lateral Sclerosis  4 Traders23 hours ago Biohaven Announces Orphan Drug Designation Request Granted For BHV-0223 In The Treatment Of Amyotrophic Lateral Sclerosis ("ALS")  TickerTech.com2 days ago Biohaven' BHV-0223 is Granted Orphan Drug Designation in the Treatment of Amyotrophic Lateral Sclerosis  PR Newswire23 hours ago

I have MS and drugs manage my disease. That's why rising costs have me very worried

When my neurologist told me that I looked better than I should and prescribed a drug for Multiple Sclerosis (MS), he emphasized that my condition would likely worsen if I did not stick to the regimen. That was in 2003. For my own health Ive stayed ...
 FOXNews.com15 hours ago Better understanding phagocytes  HealthMediciNet.com1 week ago Roche says new MS drug works better than Merck's Rebif  Reuters2 months ago
Irish Times

Prospect of medicinal cannabis use in Ireland considerably closer

Many doctors would prescribe the drug for specific illnesses including multiple sclerosis While not exactly on the cusp of legality, the prospect of medicinal cannabis becoming a reality here has drawn considerably closer with the Government's ...
 Irish Times1 week ago Many doctors would welcome ability to prescribe cannabis  Irish Times1 week ago

Montel Williams on Tackling TBI, multiple sclerosis

Montel Williams was once best known for his talk show, The Montel Williams Show, but in recent years the TV personality has become known as a vocal advocate for various causes, including veterans issues, multiple sclerosis awareness and medical ...
 CBS News1 week ago

Biogen and AbbVie Receive Health Canada Approval of Once-Monthly ZINBRYTA„¢ (Daclizumab Beta) for Multiple Sclerosis

Biogen and AbbVie Receive Health Canada Approval of Once-Monthly ZINBRYTA (Daclizumab Beta) for Multiple Sclerosis Approval Supported by Largest and Longest Head-to-Head Global Phase 3 Study Conducted in Multiple Sclerosis (MS) ZINBRYTA ...
 TickerTech.com1 day ago

Diplomat to Dispense Multiple Myeloma Combination Drug DARZALEX®

The nation's largest independent specialty pharmacy will have access to dispense DARZALEX® (daratumumab) to treat patients who have multiple myeloma. News provided by Share this article FLINT, Mich., Dec. 1, 2016 /PRNewswire/ -- Diplomat ...
 PR Newswire1 week ago DIPLOMAT PHARMACY : to Dispense Multiple Myeloma Combination Drug DARZALEX® -  4 Traders1 week ago Diplomat launches Specialty Infusion Group brand  Chain Drug Review19 hours ago Diplomat Unites Companies Under Specialty Infusion Group Brand  ADVFN India2 days ago
Manufacturing Chemist

GENEURO : and Servier Announce ANGEL-MS Extension Clinical Study in Multiple Sclerosis

The ANGEL-MS extension study will offer the 260 patients enrolled in the on-going Phase IIb CHANGE-MS study the opportunity to continue their treatment for an additional two years and will provide additional efficacy and tolerance data. Regulatory ...
 4 Traders3 days ago GeNeuro and Servier Announce ANGEL-MS Extension Clinical Study in Multiple Sclerosis  Business Wire3 days ago

6 Side Effects of MS Steroid Treatment

Whenmultiple sclerosis symptomsflare, a short course of steroids may very well be what your doctor prescribes. Typically, steroids are given intravenously for three to five days, and you may be instructed to taper the dose using an oral steroid ...
 EverydayHealth.com14 hours ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less